Sources | Names Used |
---|---|
GDSC1000 | Tivozanib |
CTRPv2 | tivozanib |
PharmacoGx | tivozanib |
Database | Identifier |
---|---|
Smiles: | CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl |
Inchikey: | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
Pubchem: | 9911830 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HBG1 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
mRNA | B3GNTL1 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
mRNA | EIF3E | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-10 |
mRNA | GBGT1 | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-10 |
mRNA | PDGFRA | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-10 |
mRNA | GNA15 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-10 |
mRNA | LYL1 | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-10 |
mRNA | PTPN7 | CTRPv2 | pan-cancer | AAC | 0.31 | 8e-10 |
mRNA | ADAMTS14 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | AC104389.2 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |